AstraZeneca announced it raked in $45.5 billion in 2023 – a $1.46 billion increase over 2022 – during their earnings report last week. While they make billions, drug companies charge Americans over four times more for prescription drugs than customers in other high-income countries.
During the call, CEO Pascal Soriot underscored his company’s greed in suing the Biden administration to block Medic...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
